{"id": "bp8125", "title": "TDOC", "selftext": "Rapidly growing global company in a beaten down healthcare sector that offers the most innovative and comprehensive solution for affordable and immediate access to healthcare. Services 130 countries and provides care in more than 30 languages. No exposure to US-China trade war. Stands to thrive in a Republican or Democratic led administration.**\ud83d\udcf7**\n\n[Teladoc Health Reports First Quarter 2019 Results | APR 30 2019](https://s21.q4cdn.com/672268105/files/doc_financials/2019/Q1/1Q19-TDOC-Earnings-Release-Final-430-v2.pdf)\n\nHighlights\n\n* Year-over-year revenue grows 43% to $128.6 million and total visits increase 75% to 1,063,000\n* EBITDA was $(13.3) million for the first quarter 2019 compared to $(10.8) million for the first quarter 2018.\n* Adjusted EBITDA was a positive $1.2 million for the first quarter 2019 compared to an adjusted EBITDA loss $(1.4) million for the first quarter 2018.\n* Total U.S. Paid Membership was 26.7 million, up 28.2% YoY.\n* Total U.S. Visit Fee Only Access was 10.2 million, up 7.3% YoY.\n* $0.43 net loss per share\n\nQ2 2019 Guidance\n\n* Total revenue to be in the range of $128 million to $131 million.\n* EBITDA loss to be in the range of $(13) million to $(15) million.\n* Adjusted EBITDA to be in the range of $5 million to $7 million.\n* Total U.S. paid membership to be in the range of 27 million to 28 million and visit-fee-only access to be available to approximately 10 million individuals.\n* Total visits to be between 775,000 and 875,000.\n* Net loss per share, based on 72.4 million weighted average shares outstanding, to be between $(0.42) and $(0.44).\n\n[Teladoc Q4'18 Earnings Conference Call | FEB 27 2019](https://s21.q4cdn.com/672268105/files/doc_financials/2018/q4/tdoc_EX_99_1-Q4-2018-2.27_FINAL-RELEASE.pdf)\n\nHighlights\n\n* Fourth-quarter revenue grows 59% to $122.7 million \n* Full-year 2018 revenue grows 79% to $417.9 million\n* Fourth-quarter total visits up 86% to 861,000; 2018 total visits up 80% to 2.6 million\n* EBITDA was $(8.3) million for the fourth quarter 2018 compared to $(17.2) million for the fourth quarter 2017.\n* EBITDA was $(35.3) million for the full year 2018 compared to $(70.4) million for the full year 2017.\n* Adjusted EBITDA was a positive $5.8 million for the fourth quarter 2018 compared to $2.4 million for the fourth quarter 2017.\n* Adjusted EBITDA was a positive $13.4 million for the full year 2018 compared to a loss of $(12.5) million for the full year 2017.\n* Total U.S. Paid Membership 22.8 million, 16% YoY growth.\n* Total Visits Q4 2018 was 861,000, up 86% YoY. \n* Total Visits full year 2018 was 2,640,000, up 80% YoY.\n* Total U.S. Visit Fee Only Access was 9.5 million.\n* Net loss per basic and diluted share was $(0.35) for the fourth quarter 2018 compared to $(0.76) for the fourth quarter 2017.\n* Net loss per basic and diluted share was $(1.47) for the full year 2018 compared to $(1.93) for the full year 2017.\n\nGuidance\n\nQ1 2019:\n\n* Total revenue to be in the range of $126 million to $129 million.\n* EBITDA loss to be in the range of $(14) million to $(16) million.\n* Adjusted EBITDA to be in the range of $0 million to positive $2 million.\n* Total U.S. paid membership to be in the range of 26 million to 26.5 million and visit-fee-only access to be available to approximately 9.8 million individuals.\n* Total visits to be between 950,000 and 1,050,000.\n* Net loss per share, based on 70.8 million weighted average shares outstanding, to be between $(0.44) and $(0.46).\n\nFull year 2019:\n\n* Total revenue to be in the range of $535 million to $545 million.\n* EBITDA loss to be in the range of $(40) million to $(50) million.\n* Adjusted EBITDA to be in the range of positive $25 million to $35 million.\n* Total U.S. paid membership to be in the range of 27 million to 29 million members and visit-fee-only access to be available to approximately 9.8 million individuals.\n* Total visits to be between 3.6 million to 3.9 million.\n* Net loss per share, based on 71.9 million weighted average shares outstanding, to be between $(1.52) and $(1.66).\n\n[MEET OUR LEADERSHIP](https://teladochealth.com/en/leadership/)\n\nJason Gorevic - CEO\n\nPreviously at Oxford Health, Wellpoint (now Anthem), and BlueCross BlueShield. Bachelor of arts in international relations at UPenn.\n\nPeter McClennen - President\n\nPreviously at Best Doctors, Allscripts Healthcare Solutions, GE Healthcare, Fujifilm Medical Systems, and AMICAS Inc.\n\nKelly Bliss - Chief Client Officer\n\nPreviously at Best Doctors, InterSystems, and TRO-Design. Bachelor\u2019s degree in industrial psychology from Nichols College.\n\nMichelle Bucaria - Chief Human Resources Officer\n\nPreviously at JP Morgan. Bachelor of science in business administration from Boston College.\n\nMike King - Chief Growth Officer\n\nPreviously at Healthways, Inc., Doctors Health Plan, and Aetna. Bachelor\u2019s degree in employment relations from Michigan State University and attended the general managers program at Harvard Business School.\n\nLewis Levy, MD, FACP - Chief Medical Officer\n\nPreviously at Best Doctors, Harvard Vanguard Medical Associates, Harvard Medical School, the Brigham and Women\u2019s Hospital. A member of IBM Watson Health for Oncology Data and Evidence Innovation Council, NBGH Institute on Health Care Costs and Solutions, and the NCQA Telehealth Expert Panel. Medical degree from the University of Rochester School of Medicine and Dentistry. He completed his residency in Internal Medicine at the Graduate Hospital of the University of Pennsylvania.\n\nJeff Nadler - Chief Information Officer\n\nPreviously at ActiveHealth Management, Marsh Inc, and Cambridge Technology Partners. Bachelor\u2019s degree in electrical engineering from Union College.\n\nCarlos Nueno - President, International\n\nPreviously at Advance Medical and Gemini Consulting. Graduated from Polytechnic School (UPC) in Barcelona, Spain, with a concentration in industrial and mechanical engineering and holds an MBA from IESE Business School.\n\nAlan Roga, MD, FACEP - President, Hospital &amp; Health Systems\n\nPreviously at Stat Doctors. Fellow of the American College of Emergency Physicians and a diplomate of the American Board of Emergency Medicine. Medical degree from the State University of New York at Stony Brook School of Medicine and a bachelor\u2019s degree from the State University of New York at Albany.\n\nDan Trencher - Senior Vice President of Product &amp; Corporate Strategy\n\nPreviously at WellPoint (now Anthem) and WellChoice. Bachelor\u2019s degree in economics from the University of Pennsylvania, and a Master of Business Administration degree from the University of Chicago.\n\nAndrew Turitz - Senior Vice President of Corporate Development\n\nPreviously at Aetna, Sandbox Industries, and Bank of America. Bachelor\u2019s degree from Stanford University and a Master of Business Administration from the Kellogg School of Management at Northwestern University.\n\nAdam Vandervoort - Chief Legal Officer\n\nPreviously at FedEx and Sullivan &amp; Cromwell LLP. J.D. degree from the University of Pennsylvania Law School, AM and AB degrees from the University of Chicago and is admitted to practice law in the states of California, Connecticut, and New York.\n\nStephany Verstraete - Chief Marketing Officer\n\nPreviously at Match.com, Expedia, Kraft, Frito-Lay, and Truveris. International Master of Business Administration from York University and an Honors Bachelor of Economics from Queen's University in Canada \n\nNews\n\n[Teladoc receives NCQA 2 year accreditation pending a corrective action review on November 18th, 2019 | May 14th 2019](https://reportcards.ncqa.org/#/other-health-care-organization/Other_001G000001uwt9pIAA)\n\n[Teladoc Health to Develop First Pediatric-Specific Consumer Telehealth Platform with Cincinnati Children\u2019s | April 11, 2019](https://www.globenewswire.com/news-release/2019/04/11/1802732/0/en/Teladoc-Health-to-Develop-First-Pediatric-Specific-Consumer-Telehealth-Platform-with-Cincinnati-Children-s.html)\n\n[Teladoc Health Launches Telemedicine Service in Canada, Expanding Portfolio of Available Healthcare Solutions | March 28, 2019](https://www.globenewswire.com/news-release/2019/03/28/1781291/0/en/Teladoc-Health-Launches-Telemedicine-Service-in-Canada-Expanding-Portfolio-of-Available-Healthcare-Solutions.html)\n\n[Teladoc to Acquire MedecinDirect, Expand Overseas Business | March 20, 2019](https://www.zacks.com/stock/news/362288/teladoc-to-acquire-medecindirect-expand-overseas-business)\n\n[Teladoc Health Introduces New and Expanded Virtual Care Capabilities for Hospitals and Health Systems | Feb. 05, 2019](https://www.globenewswire.com/news-release/2019/02/05/1710651/0/en/Teladoc-Health-Introduces-New-and-Expanded-Virtual-Care-Capabilities-for-Hospitals-and-Health-Systems.html)\n\n[Teladoc Health Expands Continuum of Services with Addition of Back Care Solution | Jan. 17, 2019](https://www.globenewswire.com/news-release/2019/01/17/1701304/0/en/Teladoc-Health-Expands-Continuum-of-Services-with-Addition-of-Back-Care-Solution.html)\n\n[Teladoc Health Launches Solution to Address Rising Prescription Drug Costs in Canada | Nov. 26, 2018](https://www.globenewswire.com/news-release/2018/11/26/1656619/0/en/Teladoc-Health-Launches-Solution-to-Address-Rising-Prescription-Drug-Costs-in-Canada.html)\n\n[Teladoc Health, USC Collaborate for Groundbreaking Study of Virtual Care Prescribing | Nov. 14, 2018](https://www.globenewswire.com/news-release/2018/11/14/1651428/0/en/Teladoc-Health-USC-Collaborate-for-Groundbreaking-Study-of-Virtual-Care-Prescribing.html)\n\n[Jefferson and Teladoc Introduce First Telehealth Fellowship | Nov. 12, 2018](https://www.globenewswire.com/news-release/2018/11/12/1649791/0/en/Jefferson-and-Teladoc-Introduce-First-Telehealth-Fellowship.html)\n\n[Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Michael | Oct. 12, 2018](https://www.globenewswire.com/news-release/2018/10/12/1620760/0/en/Free-Health-Visits-Available-Through-Teladoc-Health-to-Residents-Impacted-by-Hurricane-Michael.html)\n\n[Teladoc Health Launches Teladoc Global Care Services | Sept. 20, 2018](https://www.globenewswire.com/news-release/2018/09/20/1573726/0/en/Teladoc-Health-Launches-Teladoc-Global-Care-Services.html)\n\n[Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Florence | Sept. 14, 2018](https://www.globenewswire.com/news-release/2018/09/14/1571111/0/en/Free-Health-Visits-Available-Through-Teladoc-Health-to-Residents-Impacted-by-Hurricane-Florence.html)\n\n[Free Health Visits, Available Through Teladoc Health, to Residents Impacted by Hurricane Lane | Aug. 28, 2018](https://www.globenewswire.com/news-release/2018/08/28/1557954/0/en/Free-Health-Visits-Available-Through-Teladoc-Health-to-Residents-Impacted-by-Hurricane-Lane.html)\n\nTechnical analysis\n\nDescending triangle\n\nWedge\n\n\ud83d\udcf7\n\nInstitutions\n\nApr 18 2019 Guggenheim initiated a buy rating\n\nApr 17 2019 Stephens initiated an overweight rating with a $75 price target\n\nJan 31 2019 Berenberg initiated a but rating with a $80 price target\n\nJan 14 2019 Robert W. Baird upgraded their rating from neutral to outperform\n\n18 analyst buy ratings\n\n1 analyst hold rating\n\n0 analyst sell ratings\n\nBlackrock, Vanguard, JP Morgan Chase and Fidelity are the 4 biggest holders of TDOC, respectively, making up over 33% of ownership.", "created_utc": 1557979417, "permalink": "/r/wallstreetbets/comments/bp8125/tdoc/", "is_self": true}